Table 1.
Acronym | Identity | MW |
---|---|---|
Multidentate | ||
LeacPLD | Acetylated 5-leuenkephalin PEG lysine deoxycholate | 1505 |
ItPLD | Triiodothyronine PEG lysine deoxycholate | 1559 |
DvLPBaPL | Dabsyl-l-valine lysine PEG N-benzoyl-l-arginyl-4-amino-benzoic acid PEG lysine | 1317 |
CtLPTPL | 3-(2-([3-chloro-5-trifluoromethyl)-2-pyridinyl]oxy)-anilino)-3-oxopropanionic acid lysine PEG l-thyronine PEG lysinea | 1163 |
CtLPBaPL | 3-(2-([3-chloro-5-trifluoromethyl)-2-pyridinyl]oxy)-anilino)-3-oxopropanionic acid lysine PEG N-benzoyl-l-arginyl-4-amino-benzoic acid PEG lysine | 1287 |
DvPLLCtPCbL | Dabsyl-l-valine PEG lysine lysine 3-(2-([3-chloro-5-trifluoromethyl)-2-pyridinyl]oxy)-anilino)-3-oxopropanionic acid PEG 4-[4-(4-chlorobenzyl)piperazino]-3-nitrobenzenecarboxylic acid lysine | 1765 |
Dimeric, multidentate | ||
(LeacPLD)2LP | (Acetylated 5-leuenkephalin PEG lysine deoxycholate)2 lysine PEG | 3006 |
(ItPDP)2LL | (Triiodothyronine PEG deoxycholate PEG)2 lysine lysine | 3113 |
(DvLPBaP)2LL | (Dabsyl-l-valine lysine PEG N-benzoyl-l-arginyl-4-aminobenzoic acid PEG)2 lysine lysine | 2626 |
(DvLPBaPP)2LL | (Dabsyl-l-valine lysine PEG N-benzoyl-l-arginyl-4-aminobenzoic acid PEG PEG)2 lysine lysine | 2921 |
(DvLPBaPPP)2LL | (Dabsyl-l-valine lysine PEG N-benzoyl-l-arginyl-4-aminobenzoic acid PEG PEG PEG)2 lysine lysine | 3210 |
(DvLPBaPPPP)2LL | (Dabsyl-l-valine lysine PEG N-benzoyl-l-arginyl-4-aminobenzoic acid PEG PEG PEG PEG)2 lysine lysine | 3501 |
(DvLCsPBaPPP)2CsLL | (Dabsyl-l-valine lysine cysteic acid PEG N-benzoyl-l-arginyl-4-aminobenzoic acid PEG PEG PEG)2 cysteic acid lysine lysine | 3666 |
(DvPLLCtPCbPPP)2LL | (Dabsyl-l-valine PEG lysine lysine 3-(2-([3-chloro-5-trifluoromethyl)-2-pyridinyl]oxy)-anilino)-3-oxopropanionic acid PEG 4-[4-(4-chlorobenzyl)piperazino]-3-nitrobenzenecarboxylic acid PEG PEG PEG)2 lysine lysine | 4267 |
SHALs containing the “Ct” ligand are in bold. DOTA on the SHAL contributes an additional 400 (or 244 for biotin) Daltons to the MW.